The Impact of Pain Management on Quality of Life
- 1 July 2002
- journal article
- review article
- Published by Elsevier BV in Journal of Pain and Symptom Management
- Vol. 24 (1), S38-S47
- https://doi.org/10.1016/s0885-3924(02)00411-6
Abstract
Although its inclusion in medical research is relatively recent and its interpretation is often variable, quality of life is increasingly being recognized as one of the most important parameters to be measured in the evaluation of medical therapies, including those for pain management. Pain, when it is not effectively treated and relieved, has a detrimental effect on all aspects of quality of life. This negative impact has been found to span every age and every type and source of pain in which it has been studied. Effective analgesic therapy has been shown to improve quality of life by relieving pain. Opioid analgesics, cyclooxygenase (COX)-2 inhibitors (or coxibs), and several adjuvant analgesics for neuropathic pain have been demonstrated to significantly improve quality-of-life scores in patients with pain. Coxibs provide effective, well-tolerated analgesia without some of the issues faced with opioids—benefits that should translate into improved quality of life. Recent studies have demonstrated that the COX-2 inhibitor rofecoxib significantly improves quality of life in patients with osteoarthritis and chronic, lower back pain. Quality-of-life measurements, especially symptom distress scales, can also be used as sensitive means of differentiating one agent from another in the same class. In future pharmacotherapeutic research, quality of life should be included as an outcome domain as are the traditionally measured variables of efficacy and safety. In particular, future studies of coxibs should include symptom distress scores as important quality-of-life measurements, to identify meaningful differences between this new class of analgesics and nonselective nonsteroidal anti-inflammatory drugs.Keywords
This publication has 22 references indexed in Scilit:
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- The effects of pain severity on health-related quality of lifeCancer, 1999
- Gabapentin for the Treatment of Postherpetic NeuralgiaA Randomized Controlled TrialJAMA, 1998
- Pain and Its Treatment in Outpatients with Metastatic CancerNew England Journal of Medicine, 1994
- Symptom Distress Checklists as a Component of Quality of Life Measurement: Comparing Prompted Reports by Patient and Physician with Concurrent Adverse Event Reports via the PhysicianDrug Information Journal, 1994
- Physician Attitudes and Practice in Cancer Pain Management: A Survey From the Eastern Cooperative Oncology GroupAnnals of Internal Medicine, 1993
- Quality of Life and Antihypertensive Therapy in Men -- A Comparison of Captopril with EnalaprilNew England Journal of Medicine, 1993
- Utility approach to measuring health-related quality of lifeJournal of Chronic Diseases, 1987
- Survey of Pain in the United States: The Nuprin Pain ReportThe Clinical Journal of Pain, 1986